Chromosome Analysis, Hematologic Disorders, Bone Marrow
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Assisting in the diagnosis and classification of certain malignant hematological disorders
Evaluation of prognosis in patients with certain malignant hematologic disorders
Monitoring effects of treatment
Monitoring patients in remission
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
The following algorithms are available in Special Instructions:
-Acute Promyelocytic Leukemia: Guideline to Diagnosis and Follow-up
-Myelodysplastic Syndrome: Guideline to Diagnosis and Follow-up
-Myeloproliferative Neoplasm: A Diagnostic Approach to Bone Marrow Evaluation
-Malignant Lymphoma, Guideline for Bone Marrow Staging Studies
-Laboratory Screening Tests for Suspected Multiple Myeloma
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
- Laboratory Screening Tests for Suspected Multiple Myeloma
- Myeloproliferative Neoplasm: A Diagnostic Approach to Bone Marrow Evaluation
- Malignant Lymphoma, Guideline for Bone Marrow Staging Studies
- Myelodysplastic Syndrome: Guideline to Diagnosis and Follow-up
- Acute Promyelocytic Leukemia: Guideline to Diagnosis and Follow-up
Cell Culture without Mitogens*
Includes 2 banded karyograms, analysis of 20 or more metaphases, and other techniques when required.
*In addition to the cell culture without mitogens, a CpG-stimulated culture will be added and 10 additional cells will be analyzed for any specimen received from a patient age 30 or older with a reason for referral of chronic lymphocytic leukemia, small lymphocytic leukemia, lymphocytosis, Waldenstrom macroglobulinemia, or when test FCLL / Chronic Lymphocytic Leukemia (CLL), FISH is ordered concurrently.
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Hematologic Chromosome Analysis
Karyotype, Bone Marrow